Koninklijke Philips Debt to Equity Ratio 2012-2026 | PHG
Current and historical debt to equity ratio values for Koninklijke Philips (PHG) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Koninklijke Philips debt/equity for the three months ending March 31, 2026 was 0.63.
| Koninklijke Philips Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2026-03-31 | $18.55B | $13.36B | 1.39 |
| 2025-12-31 | $18.05B | $12.43B | 1.45 |
| 2025-09-30 | $18.42B | $12.37B | 1.49 |
| 2025-06-30 | $18.13B | $11.82B | 1.53 |
| 2025-03-31 | $16.27B | $12.36B | 1.32 |
| 2024-09-30 | $0.00B | 0.00 | |
| 2024-06-30 | $18.91B | $12.84B | 1.47 |
| 2023-06-30 | $18.92B | $13.26B | 1.43 |
| 2023-03-31 | $0.00B | 0.00 | |
| 2022-06-30 | $18.86B | $15.71B | 1.20 |
| 2021-06-30 | $20.51B | $14.44B | 1.42 |
| 2020-06-30 | $18.17B | $12.09B | 1.50 |
| 2019-06-30 | $16.21B | $13.41B | 1.21 |
| 2018-06-30 | $15.65B | $13.96B | 1.12 |
| 2017-06-30 | $17.25B | $15.12B | 1.14 |
| 2016-12-31 | $20.80B | $14.95B | 1.39 |
| 2016-09-30 | $20.57B | $13.91B | 1.48 |
| 2016-06-30 | $21.18B | $13.94B | 1.52 |
| 2016-03-31 | $20.24B | $12.59B | 1.61 |
| 2015-12-31 | $21.32B | $13.08B | 1.63 |
| 2015-09-30 | $20.73B | $12.86B | 1.61 |
| 2015-06-30 | $21.43B | $12.73B | 1.68 |
| 2015-03-31 | $22.91B | $12.98B | 1.77 |
| 2014-12-31 | $23.11B | $14.58B | 1.59 |
| 2014-09-30 | $22.45B | $14.60B | 1.54 |
| 2014-06-30 | $20.44B | $14.76B | 1.39 |
| 2014-03-31 | $20.49B | $15.11B | 1.36 |
| 2013-12-31 | $20.37B | $14.91B | 1.37 |
| 2013-09-30 | $21.69B | $14.51B | 1.50 |
| 2013-06-30 | $21.97B | $14.11B | 1.56 |
| 2013-03-31 | $23.15B | $14.79B | 1.57 |
| 2012-12-31 | $23.03B | $14.37B | 1.60 |
| 2012-09-30 | $21.27B | $15.12B | 1.41 |
| 2012-06-30 | $21.89B | $15.65B | 1.40 |
| 2012-03-31 | $22.74B | $16.11B | 1.41 |
| 2011-12-31 | $23.09B | $17.26B | 1.34 |
| 2011-09-30 | $20.92B | $18.32B | 1.14 |
| 2011-06-30 | $20.18B | $18.87B | 1.07 |
| 2011-03-31 | $21.67B | $19.31B | 1.12 |
| 2010-12-31 | $22.81B | $20.04B | 1.14 |
| 2010-09-30 | $21.44B | $20.43B | 1.05 |
| 2010-06-30 | $23.63B | $20.16B | 1.17 |
| 2010-03-31 | $23.85B | $20.32B | 1.17 |
| 2009-12-31 | $22.22B | $20.35B | 1.09 |
| 2009-09-30 | $22.83B | $19.15B | 1.19 |
| 2009-06-30 | $21.41B | $18.15B | 1.18 |
| 2009-03-31 | $21.73B | $19.81B | 1.10 |
| 2008-12-31 | $24.71B | $23.89B | 1.03 |
| 2008-09-30 | $24.03B | $27.34B | 0.88 |
| 2008-06-30 | $23.47B | $29.64B | 0.79 |
| 2008-03-31 | $26.54B | $30.30B | 0.88 |
| 2007-12-31 | $20.10B | $29.73B | 0.68 |
| 2007-09-30 | $20.09B | $28.59B | 0.70 |
| 2007-06-30 | $19.51B | $29.80B | 0.66 |
| 2007-03-31 | $20.14B | $28.78B | 0.70 |
| 2006-12-31 | $19.47B | $28.88B | 0.67 |
| 2006-09-30 | $19.87B | $30.37B | 0.65 |
| 2006-06-30 | $20.43B | $25.09B | 0.82 |
| 2006-03-31 | $20.89B | $25.18B | 0.83 |
| 2005-12-31 | $21.41B | $20.75B | 1.03 |
| 2005-09-30 | $19.60B | $19.94B | 0.98 |
| 2005-06-30 | $19.72B | $19.77B | 1.00 |
| 2005-03-31 | $20.54B | $18.81B | 1.09 |
| 2004-12-31 | $21.47B | $20.11B | 1.07 |
| 2004-09-30 | $19.87B | $18.43B | 1.08 |
| 2004-06-30 | $20.83B | $16.98B | 1.23 |
| 2004-03-31 | $22.20B | $16.59B | 1.34 |
| 2003-12-31 | $20.45B | $16.08B | 1.27 |
| 2003-09-30 | $19.44B | $14.83B | 1.31 |
| 2003-06-30 | $19.99B | $14.90B | 1.34 |
| 2003-03-31 | $19.85B | $14.08B | 1.41 |
| 2002-12-31 | $19.26B | $14.59B | 1.32 |
| 2002-09-30 | $19.08B | $15.66B | 1.22 |
| 2002-06-30 | $18.77B | $16.19B | 1.16 |
| 2002-03-31 | $17.84B | $15.93B | 1.12 |
| 2001-12-31 | $17.73B | $16.35B | 1.08 |
| 2001-09-30 | $16.36B | $17.23B | 0.95 |
| 2001-06-30 | $15.82B | $18.19B | 0.87 |
| 2001-03-31 | $16.55B | $19.96B | 0.83 |
| 2000-12-31 | $15.70B | $20.31B | 0.77 |
| 2000-09-30 | $15.38B | $17.57B | 0.88 |
| 2000-06-30 | $14.45B | $17.43B | 0.83 |
| 2000-03-31 | $15.32B | $15.17B | 1.01 |
| 1999-12-31 | $14.89B | $14.91B | 1.00 |
| 1999-09-30 | $14.63B | $14.52B | 1.01 |
| 1999-06-30 | $14.56B | $14.50B | 1.00 |
| 1999-03-31 | $15.26B | $16.70B | 0.91 |
| 1998-12-31 | $15.53B | $15.80B | 0.98 |
| 1998-09-30 | $0.00B | 0.00 | |
| 1998-06-30 | $0.00B | 0.00 | |
| 1998-03-31 | $0.00B | 0.00 | |
| 1997-12-31 | $20.41B | $9.93B | 2.06 |
| 1997-09-30 | $0.00B | 0.00 | |
| 1997-06-30 | $0.00B | 0.00 | |
| 1997-03-31 | $0.00B | 0.00 | |
| 1996-12-31 | $23.30B | $9.27B | 2.52 |
| 1996-09-30 | $0.00B | 0.00 | |
| 1996-06-30 | $0.00B | 0.00 | |
| 1996-03-31 | $0.00B | 0.00 | |
| 1995-12-31 | $22.40B | $10.05B | 2.23 |
| 1995-09-30 | $0.00B | 0.00 | |
| 1995-06-30 | $0.00B | 0.00 | |
| 1995-03-31 | $0.00B | 0.00 | |
| 1994-12-31 | $10.04B | $4.30B | 2.33 |
| 1994-09-30 | $0.00B | 0.00 | |
| 1994-06-30 | $0.00B | 0.00 | |
| 1994-03-31 | $0.00B | 0.00 | |
| 1993-12-31 | $18.69B | $6.14B | 3.04 |
| 1993-09-30 | $0.00B | 0.00 | |
| 1992-12-31 | $0.00B | 0.00 | |
| 1990-12-31 | $20.81B | $6.06B | 3.44 |
| 1989-12-31 | $16.71B | $7.87B | 2.12 |
| 1988-12-31 | $14.52B | $9.29B | 1.56 |
| 1987-12-31 | $13.28B | $8.64B | 1.54 |
| 1986-12-31 | $0.19B | $0.95B | 0.20 |
| 1986-06-30 | $0.00B | 0.00 | |
| 1986-03-31 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $27.260B | $20.173B |
| Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $174.688B | 19.48 |
| Stryker (SYK) | United States | $129.889B | 24.88 |
| Medtronic (MDT) | Ireland | $111.968B | 15.57 |
| EssilorLuxottica (ESLOY) | France | $107.724B | 0.00 |
| Boston Scientific (BSX) | United States | $91.831B | 20.26 |
| Medline (MDLN) | United States | $59.904B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.712B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $33.391B | 15.98 |
| ResMed (RMD) | United States | $33.341B | 22.26 |
| Agilent Technologies (A) | United States | $32.516B | 20.44 |
| Terumo (TRUMY) | Japan | $19.854B | 23.21 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.025B | 11.36 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.227B | 0.00 |
| Insulet (PODD) | United States | $13.640B | 39.54 |
| Baxter (BAX) | United States | $8.854B | 7.56 |
| Sunny Optical Technology (SNPTF) | China | $8.381B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.537B | 28.15 |
| Demant (WILYY) | Denmark | $6.395B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.247B | 15.90 |
| Envista Holdings (NVST) | United States | $4.301B | 21.99 |
| BillionToOne (BLLN) | United States | $3.729B | 0.00 |
| DiaSorin S.p.A (DSRLF) | Italy | $3.666B | 0.00 |
| ICU Medical (ICUI) | United States | $3.141B | 20.47 |
| Prestige Consumer Healthcare (PBH) | United States | $2.676B | 12.62 |
| Haemonetics (HAE) | United States | $2.664B | 11.65 |
| LeMaitre Vascular (LMAT) | United States | $2.611B | 48.16 |
| Phibro Animal Health (PAHC) | United States | $2.347B | 20.67 |
| GN Store Nord (GNNDY) | Denmark | $2.270B | 21.90 |
| Neogen (NEOG) | United States | $2.050B | 44.86 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.028B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $1.794B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.654B | 32.89 |
| Curaleaf Holdings (CURLF) | Canada | $1.584B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.495B | 3.96 |
| AtriCure (ATRC) | United States | $1.429B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.386B | 15.91 |
| Kestra Medical Technologies (KMTS) | United States | $1.043B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.953B | 164.50 |
| QuidelOrtho (QDEL) | United States | $0.943B | 6.53 |
| Lumexa Imaging Holdings (LMRI) | United States | $0.896B | 0.00 |
| InMode (INMD) | Israel | $0.857B | 9.40 |
| Omeros (OMER) | United States | $0.827B | 6.49 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.789B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.766B | 0.00 |
| CeriBell (CBLL) | United States | $0.683B | 0.00 |
| Brainsway (BWAY) | Israel | $0.546B | 55.68 |
| Valneva SE (VALN) | France | $0.532B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.468B | 11.18 |
| Cresco Labs (CRLBF) | United States | $0.458B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.424B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.415B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.367B | 25.70 |
| SNDL (SNDL) | Canada | $0.366B | 0.00 |
| Cerus (CERS) | United States | $0.363B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.311B | 126.00 |
| Evolus (EOLS) | United States | $0.278B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.259B | 0.00 |
| MacroGenics (MGNX) | United States | $0.229B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Accendra Health (ACH) | United States | $0.215B | 2.96 |
| Utah Medical Products (UTMD) | United States | $0.210B | 18.94 |
| High Tide (HITI) | Canada | $0.205B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.205B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.194B | 57.17 |
| TerrAscend (TSNDF) | Canada | $0.193B | 0.00 |
| Organigram Global (OGI) | Canada | $0.191B | 0.00 |
| Apyx Medical (APYX) | United States | $0.166B | 0.00 |
| Quanterix (QTRX) | United States | $0.158B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.152B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.145B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.143B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.133B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| Jushi Holdings (JUSHF) | United States | $0.101B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.090B | 11.73 |
| Exagen (XGN) | United States | $0.073B | 0.00 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| ImmuCell (ICCC) | United States | $0.064B | 0.00 |
| Biote (BTMD) | United States | $0.063B | 3.46 |
| INLIF (INLF) | China | $0.053B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.038B | 0.00 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Nephros (NEPH) | United States | $0.032B | 26.91 |
| United-Guardian (UG) | United States | $0.030B | 14.23 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Jin Medical (ZJYL) | China | $0.018B | 0.00 |
| Modular Medical (MODD) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Agape ATP (ATPC) | $0.003B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |